A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus

NCT00263276 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

389

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: dapagliflozin
DRUG: dapagliflozin
DRUG: dapagliflozin
DRUG: dapagliflozin
DRUG: dapagliflozin
DRUG: placebo
DRUG: metformin

Sponsor

AstraZeneca

Collaborators

[object Object]